Cited by 48Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration

Open access
Casaletto, K. B., Staffaroni, A. M., Wolf, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto‐Reilly, K. +33 more·2020·Alzheimer's & Dementia

Abstract

Introduction: Leisure activities impact brain aging and may be prevention targets. We characterized how physical and cognitive activities relate to brain health for the first time in autosomal dominant frontotemporal lobar degeneration (FTLD). Methods: A total of 105 mutation carriers (C9orf72/MAPT/GRN) and 69 non‐carriers reported current physical and cognitive activities at baseline, and completed longitudinal neurobehavioral assessments and brain magnetic resonance imaging (MRI) scans. Results: Greater physical and cognitive activities were each associated with an estimated >55% slower clinical decline per year among dominant gene carriers. There was also an interaction between leisure activities and frontotemporal atrophy on cognition in mutation carriers. High‐activity carriers with frontotemporal atrophy (−1 standard deviation/year) demonstrated >two‐fold better cognitive performances per year compared to their less active peers with comparable atrophy rates. Discussion: Active lifestyles were associated with less functional decline and moderated brain‐to‐behavior relationships longitudinally. More active carriers “outperformed” brain volume, commensurate with a cognitive reserve hypothesis. Lifestyle may confer clinical resilience, even in autosomal dominant FTLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12001

Cites

54 of 55 references verified1 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In familial frontotemporal dementia mutation carriers, greater intensity of physical and cognitive activities is associated with slower clinical decline and rate of atrophy on MRI.

    “Evidence suggests that in familial frontotemporal dementia mutation carriers, greater intensity of physical and cognitive activities are associated with slower clinical decline and rate of atrophy on MRI.80”

    From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [80]

    The Results section reports that greater baseline physical and cognitive activity were associated with slower clinical decline in mutation carriers. It does not establish slower MRI-measured atrophy: associations with longitudinal brain-volume change did not reach statistical significance. The reported atrophy interactions concern cognitive performance despite comparable volume loss, not a reduced rate of atrophy. Page numbers were not supplied in our copy. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Beneficial lifestyles confer cognitive reserve, slow progressive neurodegeneration, and ameliorate pathological events and phenotypes of neurodegenerative diseases.

    “these beneficial lifestyles are also adapted to confer a cognitive reserve, slow progressive neurodegeneration, and ameliorate pathological events and the phenotypes of neurodegenerative diseases.491”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [41]Stern Y Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 2012; 11: 1006– 12. doi: 10.1016/S1474-4422(12)70191-6. 23079557 PMC3507991 · DOI · Paper page
  2. [53]Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer’s mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 2007; 88: 277– 94. doi: 10.1016/j.nlm.2007.07.007. 17714960 PMC2083653 · DOI

Cited by

Sorted by citations

Authors
Casaletto, K. B., Staffaroni, A. M., Wolf, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto‐Reilly, K., Elahi, F. M., Fields, J., Fong, J. C., Forsberg, L., Ghoshal, N., Graff‐Radford, N., Grossman, M., Heuer, H. W., Hsiung, G. ‐., Huey, E. D., Irwin, D., Kantarci, K., Kaufer, D., Kerwin, D., Knopman, D., Kornak, J., Kramer, J. H., Litvan, I., Mackenzie, I. R., Mendez, M., Miller, B., Rademakers, R., Ramos, E. M., Rascovsky, K., Roberson, E. D., Syrjanen, J. A., Tartaglia, M. C., Weintraub, S., Boeve, B., Boxer, A. L., Rosen, H., Yaffe, K., & Study, T. A.
Affiliations
  • University of California, San Francisco (US)
  • Case Western Reserve University (US)
  • Mayo Clinic (US)
  • University of California, Los Angeles (US)
  • Harvard University (US)
  • University of Washington (US)
  • Washington University in St. Louis (US)
  • University of Pennsylvania (US)
  • University of British Columbia (CA)
  • Columbia University (US)
  • University of North Carolina at Chapel Hill (US)
  • The University of Texas Southwestern Medical Center (US)
  • University of California San Diego (US)
  • University of Alabama at Birmingham (US)
  • University of Toronto (CA)
  • Mesulam Center for Cognitive Neurology and Alzheimer's Disease Northwestern University Chicago Illinois USA
Corresponding author
Casaletto, K. B.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-01
Volume
16
Issue
1
Pages
91-105
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W3000095436
Cited by
48
References
54
Citations by year
2026: 8 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 5
FWCI
5.29
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS; (U01AG045390)
  • Advancing Research and Treatment in Frontotemporal Lobar Degeneration (U54NS092089, K23AG058752,, L30AG057123)
  • Larry L. Hillblom Fellowship (2017-A-004-FEL)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72
MeSH terms
Aged, Atrophy, Cognition, Female, Humans, Leisure Activities, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Exercise, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review